Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
Market Analysis and Insights: Global Huntington’s Disease Treatment Market
The global Huntington’s Disease Treatment market size is projected to reach US$ 1170.6 million by 2026, from US$ 232.2 million in 2020, at a CAGR of 30.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Huntington’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Huntington’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Huntington’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Huntington’s Disease Treatment market.
Huntington’s Disease Treatment Breakdown Data by Type
Symptomatic Therapy
Disease-Modifying Therapy
Huntington’s Disease Treatment Breakdown Data by Application
Hospitals
Ambulatory Surgical Centers
Based on regional and country-level analysis, the Huntington’s Disease Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Huntington’s Disease Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
Market Analysis and Insights: Global Huntington’s Disease Treatment Market
The global Huntington’s Disease Treatment market size is projected to reach US$ 1170.6 million by 2026, from US$ 232.2 million in 2020, at a CAGR of 30.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Huntington’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Huntington’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Huntington’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Huntington’s Disease Treatment market.
Huntington’s Disease Treatment Breakdown Data by Type
Symptomatic Therapy
Disease-Modifying Therapy
Huntington’s Disease Treatment Breakdown Data by Application
Hospitals
Ambulatory Surgical Centers
Based on regional and country-level analysis, the Huntington’s Disease Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Huntington’s Disease Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Huntington’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Symptomatic Therapy
1.2.3 Disease-Modifying Therapy
1.3 Market by Application
1.3.1 Global Huntington’s Disease Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Huntington’s Disease Treatment Market Perspective (2015-2026)
2.2 Global Huntington’s Disease Treatment Growth Trends by Regions
2.2.1 Huntington’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Huntington’s Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Huntington’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Huntington’s Disease Treatment Players by Market Size
3.1.1 Global Top Huntington’s Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Huntington’s Disease Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Huntington’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Huntington’s Disease Treatment Revenue
3.4 Global Huntington’s Disease Treatment Market Concentration Ratio
3.4.1 Global Huntington’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Huntington’s Disease Treatment Revenue in 2019
3.5 Key Players Huntington’s Disease Treatment Area Served
3.6 Key Players Huntington’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Huntington’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Huntington’s Disease Treatment Breakdown Data by Type (2015-2026)
4.1 Global Huntington’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Huntington’s Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Huntington’s Disease Treatment Breakdown Data by Application (2015-2026)
5.1 Global Huntington’s Disease Treatment Historic Market Size by Application (2015-2020)
5.2 Global Huntington’s Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Huntington’s Disease Treatment Market Size (2015-2026)
6.2 North America Huntington’s Disease Treatment Market Size by Type (2015-2020)
6.3 North America Huntington’s Disease Treatment Market Size by Application (2015-2020)
6.4 North America Huntington’s Disease Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Huntington’s Disease Treatment Market Size (2015-2026)
7.2 Europe Huntington’s Disease Treatment Market Size by Type (2015-2020)
7.3 Europe Huntington’s Disease Treatment Market Size by Application (2015-2020)
7.4 Europe Huntington’s Disease Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Huntington’s Disease Treatment Market Size (2015-2026)
8.2 China Huntington’s Disease Treatment Market Size by Type (2015-2020)
8.3 China Huntington’s Disease Treatment Market Size by Application (2015-2020)
8.4 China Huntington’s Disease Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Huntington’s Disease Treatment Market Size (2015-2026)
9.2 Japan Huntington’s Disease Treatment Market Size by Type (2015-2020)
9.3 Japan Huntington’s Disease Treatment Market Size by Application (2015-2020)
9.4 Japan Huntington’s Disease Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Huntington’s Disease Treatment Market Size (2015-2026)
10.2 Southeast Asia Huntington’s Disease Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Huntington’s Disease Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Huntington’s Disease Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Huntington’s Disease Treatment Introduction
11.1.4 Bausch Health Revenue in Huntington’s Disease Treatment Business (2015-2020))
11.1.5 Bausch Health Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Introduction
11.2.4 Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Wave Life Sciences
11.3.1 Wave Life Sciences Company Details
11.3.2 Wave Life Sciences Business Overview
11.3.3 Wave Life Sciences Huntington’s Disease Treatment Introduction
11.3.4 Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.3.5 Wave Life Sciences Recent Development
11.4 Ionis Pharmaceuticals/ Roche
11.4.1 Ionis Pharmaceuticals/ Roche Company Details
11.4.2 Ionis Pharmaceuticals/ Roche Business Overview
11.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Introduction
11.4.4 Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.4.5 Ionis Pharmaceuticals/ Roche Recent Development
11.5 Raptor Pharmaceuticals
11.5.1 Raptor Pharmaceuticals Company Details
11.5.2 Raptor Pharmaceuticals Business Overview
11.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Introduction
11.5.4 Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.5.5 Raptor Pharmaceuticals Recent Development
11.6 Prana Biotechnology
11.6.1 Prana Biotechnology Company Details
11.6.2 Prana Biotechnology Business Overview
11.6.3 Prana Biotechnology Huntington’s Disease Treatment Introduction
11.6.4 Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.6.5 Prana Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Huntington’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Symptomatic Therapy
1.2.3 Disease-Modifying Therapy
1.3 Market by Application
1.3.1 Global Huntington’s Disease Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Huntington’s Disease Treatment Market Perspective (2015-2026)
2.2 Global Huntington’s Disease Treatment Growth Trends by Regions
2.2.1 Huntington’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Huntington’s Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Huntington’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Huntington’s Disease Treatment Players by Market Size
3.1.1 Global Top Huntington’s Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Huntington’s Disease Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Huntington’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Huntington’s Disease Treatment Revenue
3.4 Global Huntington’s Disease Treatment Market Concentration Ratio
3.4.1 Global Huntington’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Huntington’s Disease Treatment Revenue in 2019
3.5 Key Players Huntington’s Disease Treatment Area Served
3.6 Key Players Huntington’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Huntington’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Huntington’s Disease Treatment Breakdown Data by Type (2015-2026)
4.1 Global Huntington’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Huntington’s Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Huntington’s Disease Treatment Breakdown Data by Application (2015-2026)
5.1 Global Huntington’s Disease Treatment Historic Market Size by Application (2015-2020)
5.2 Global Huntington’s Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Huntington’s Disease Treatment Market Size (2015-2026)
6.2 North America Huntington’s Disease Treatment Market Size by Type (2015-2020)
6.3 North America Huntington’s Disease Treatment Market Size by Application (2015-2020)
6.4 North America Huntington’s Disease Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Huntington’s Disease Treatment Market Size (2015-2026)
7.2 Europe Huntington’s Disease Treatment Market Size by Type (2015-2020)
7.3 Europe Huntington’s Disease Treatment Market Size by Application (2015-2020)
7.4 Europe Huntington’s Disease Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Huntington’s Disease Treatment Market Size (2015-2026)
8.2 China Huntington’s Disease Treatment Market Size by Type (2015-2020)
8.3 China Huntington’s Disease Treatment Market Size by Application (2015-2020)
8.4 China Huntington’s Disease Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Huntington’s Disease Treatment Market Size (2015-2026)
9.2 Japan Huntington’s Disease Treatment Market Size by Type (2015-2020)
9.3 Japan Huntington’s Disease Treatment Market Size by Application (2015-2020)
9.4 Japan Huntington’s Disease Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Huntington’s Disease Treatment Market Size (2015-2026)
10.2 Southeast Asia Huntington’s Disease Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Huntington’s Disease Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Huntington’s Disease Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Huntington’s Disease Treatment Introduction
11.1.4 Bausch Health Revenue in Huntington’s Disease Treatment Business (2015-2020))
11.1.5 Bausch Health Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Introduction
11.2.4 Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Wave Life Sciences
11.3.1 Wave Life Sciences Company Details
11.3.2 Wave Life Sciences Business Overview
11.3.3 Wave Life Sciences Huntington’s Disease Treatment Introduction
11.3.4 Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.3.5 Wave Life Sciences Recent Development
11.4 Ionis Pharmaceuticals/ Roche
11.4.1 Ionis Pharmaceuticals/ Roche Company Details
11.4.2 Ionis Pharmaceuticals/ Roche Business Overview
11.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Introduction
11.4.4 Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.4.5 Ionis Pharmaceuticals/ Roche Recent Development
11.5 Raptor Pharmaceuticals
11.5.1 Raptor Pharmaceuticals Company Details
11.5.2 Raptor Pharmaceuticals Business Overview
11.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Introduction
11.5.4 Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.5.5 Raptor Pharmaceuticals Recent Development
11.6 Prana Biotechnology
11.6.1 Prana Biotechnology Company Details
11.6.2 Prana Biotechnology Business Overview
11.6.3 Prana Biotechnology Huntington’s Disease Treatment Introduction
11.6.4 Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2015-2020)
11.6.5 Prana Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
